Advances in Hematology / 2015 / Article / Tab 1

Research Article

Predictors of Outcome and Severity in Adult Filipino Patients with Febrile Neutropenia

Table 1

Baseline clinical characteristics of febrile neutropenia cases.

Clinical parameterOutcome frequency (%)
Complicated group
(50.4)
Noncomplicated group
(49.6)

Age
 Mean (SD)41.24 (15.99)40 (11.89)
 Median40.542
 Range19–7119–61
Sex
 Male23 (39.7)24 (42.1)
 Female35 (60.3)33 (57.9)
Primary underlying disease
 Leukemia29 (50)27 (47.4)
 Lymphoma (all sites)1 (1.7)1 (1.8)
 Solid-organ tumor9 (15.5)18 (31.6)
 Bone marrow failure state6 (10.3)3 (5.2)
 Others13 (22.4)8 (14.0)
Comorbid
 None41 (70.7)43 (7.5)
 Cardiovascular disease8 (13.8)13 (22.8)
 Pulmonary disease1 (1.7)0
 Liver disease01 (1.8)
 Renal disease3 (5.2)0
 Diabetes mellitus2 (3.4)0
 Others3 (5.2)0
Outcome
 Discharged improved32 (60.3)57 (100.0)
 Expired22 (37.9)0
 Left against advice4 (6.9)0
Status of treatment
 Treated/on treatment32 (55.2)40 (70.2)
 Remission02 (3.5)
 Relapse3 (5.2)3 (5.3)
 Not on treatment23 (39.7)12 (21)
Type of treatment
 Chemotherapy26 (44.8)28 (49.1)
 Combination therapy6 (10.3)17 (29.8)
 None26 (44.8)12 (21.1)
G-CSF use
 Yes16 (27.6)23 (40.3)
 No42 (72.4)34 (59.7)
Duration of fever prior to admission
7 days42 (72.4)51 (89.5)
7 days16 (27.6)6 (10.5)
Duration of neutropenia during admission
7 days27 (46.6)35 (61.4)
7 days31 (53.4)22 (39.6)
Recovery from neutropenia
 Yes17 (29.3)27 (47.4)
 No41 (70.7)30 (52.6)